Association between non-alcoholic fatty liver disease and chronic plaque psoriasis: Deep to the skin
Psoriasis and fatty liver disease
Keywords:Chronic plaque psoriasis, NAFLD, BMI
AbstractObjective To compare the frequency of Non-Alcoholic Fatty Liver Disease (NAFLD) in psoriasis patients (cases) with. non-psoriasis patients (controls) and to stratify it with respect to various independent variables in both groups. Methods It was a case-control study done at the Dermatology department, Lady Reading Hospital, Peshawar, with a total of 160 participants and 80 in each group. NAFDL was diagnosed with the help of abdominal ultrasound and considered relevant only after other secondary causes of NAFLD (as mentioned in exclusion criteria) were excluded. Results The mean age in cases and controls was 36±4.77 years and 40±13.12 years respectively. The cases included 59 % male and 41% female while controls groups consisted of 51% female and 49% male patients. In Cases group, 30 patients (37.5%) had NAFLD while in Controls 16 patients (20%) patients had NAFLD disease, with p-valve =0.0144). Conclusion Our study concludes that there is a positive association between chronic plaque psoriasis with NAFLD compared with age, gender, and body mass index (BMI)-matched non-psoriasis.
Jiang S, Hinchliffe TE, Wu T. Biomarkers of an autoimmune skin disease—psoriasis. Genomics, proteomics & bioinformatics. 2015 Aug 1;13(4):224-33.
Campanati A, Marani A, Martina E, Diotallevi F, Radi G, Offidani A. Psoriasis as an immune-mediated and inflammatory systemic disease: From pathophysiology to novel therapeutic approaches. Biomedicines. 2021 Oct 21;9(11):1511.
Singh RK, Lee KM, Ucmak D, Brodsky M, Atanelov Z, Farahnik B, Abrouk M, Nakamura M, Zhu TH, Liao W. Erythrodermic psoriasis: pathophysiology and current treatment perspectives. Psoriasis: Targets and Therapy. 2016 Jul 20:93-104..
Mahajan R, Handa S. Pathophysiology of psoriasis. Indian Journal of Dermatology, Venereology and Leprology. 2013 Jul 1;79:1.
Gisondi P, Bellinato F, Girolomoni G. Topographic differential diagnosis of chronic plaque psoriasis: challenges and tricks. Journal of Clinical Medicine. 2020 Nov 8;9(11):3594.
Boehncke WH, Boehncke S, Schön MP. Managing comorbid disease in patients with psoriasis. Bmj. 2010 Jan 15;340.
Horreau C, Pouplard C, Brenaut E, Barnetche T, Misery L, Cribier B, Jullien D, Aractingi S, Aubin F, Joly P, Le Maître M. Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. Journal of the European Academy of Dermatology and Venereology. 2013 Aug;27:12-29.
Solomon G. The role of weight loss in the treatment of psoriasis: evidence that psoriasis is a systemic inflammatory disorder linked to metabolic syndrome. British Journal of Dermatology. 2014 Mar 1;170(3):492-3.
Rattanakaemakorn P, Fleischer AB. Psoriasis or obesity is a risk factor for nonalcoholic fatty liver disease. Journal of the American Academy of Dermatology. 2014 Sep 1;71(3):588.
Gisondi P, Barba E, Girolomoni G. Non‐alcoholic fatty liver disease fibrosis score in patients with psoriasis. Journal of the European Academy of Dermatology and Venereology. 2016 Feb;30(2):282-7.
Sohail SU, Iqbal N, Kumar A, Fatimee S, Khan A, Nangrejo R. Prevalence of Psoriasis Vulgaris and Its Associated Risk Factors in Pakistan. JPRI [Internet]. 14Sep.2021 [cited 27Aug.2022];33(43B):390-5.
Gisondi P, Targher G, Zoppini G, Girolomoni G. Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. Journal of hepatology. 2009 Oct 1;51(4):758-64.
Awosika O, Eleryan MG, Rengifo-Pardo M, Doherty L, Martin LW, Ehrlich A. A case-control study to evaluate the prevalence of nonalcoholic fatty liver disease among patients with moderate-to-severe psoriasis. The Journal of Clinical and Aesthetic Dermatology. 2018 Jun;11(6):33.
Roberts KK, Cochet AE, Lamb PB, Brown PJ, Battafarano DF, Brunt EM, Harrison SA. The prevalence of NAFLD and NASH among patients with psoriasis in a tertiary care dermatology and rheumatology clinic. Alimentary pharmacology & therapeutics. 2015 Feb;41(3):293-300.
Madanagobalane S, Anandan S. The increased prevalence of non‐alcoholic fatty liver disease in psoriatic patients: a study from South India. Australasian journal of dermatology. 2012 Aug;53(3):190-7.
van der Voort EA, Koehler EM, Dowlatshahi EA, Hofman A, Stricker BH, Janssen HL, Schouten JN, Nijsten T. Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: results from a population-based study. Journal of the American Academy of Dermatology. 2014 Mar 1;70(3):517-24.
Miele L, Vallone S, Cefalo C, La Torre G, Di Stasi C, Vecchio FM, D’Agostino M, Gabrieli ML, Vero V, Biolato M, Pompili M. Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. Journal of hepatology. 2009 Oct 1;51(4):778-86.
Amarapurkar D, Kamani P, Patel N, Gupte P, Kumar P, Agal S, Baijal R, Lala S, Chaudhary D, Deshpande A. Prevalence of non-alcoholic fatty liver disease: population-based study. Annals of hepatology. 2007 Jul 1;6(3):161-3.
Wang L, Guo J, Lu J. Risk factor compositions of nonalcoholic fatty liver disease change with body mass index in males and females. Oncotarget. 2016 Jun 6;7(24):35632..
Kim H, Kisseleva T, Brenner DA. Aging and liver disease. Current opinion in gastroenterology. 2015 May;31(3):184.
Mantovani A, Gisondi P, Lonardo A, Targher G. Relationship between non-alcoholic fatty liver disease and psoriasis: a novel hepato-dermal axis?. International journal of molecular sciences. 2016 Feb 5;17(2):217.
Candia R, Ruiz A, Torres‐Robles R, Chávez‐Tapia N, Méndez‐Sánchez N, Arrese M. Risk of non‐alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta‐analysis. Journal of the European Academy of Dermatology and Venereology. 2015 Apr;29(4):656-62.
Kwak MS, Kim D. Non-alcoholic fatty liver disease and lifestyle modifications, focusing on physical activity. The Korean journal of internal medicine. 2018 Jan;33(1):64